The Cochrane Handbook for Systematic Reviews of Interventions is the methodological reference manual produced by Cochrane that defines best practice for conducting and reporting systematic reviews of healthcare interventions. It is the working manual for every Cochrane Review Group and the de facto standard for non-Cochrane reviewers who want their work to meet contemporary methodological expectations.
The current edition is Version 6.5, released in 2024 and edited by Julian Higgins, James Thomas, Jacqueline Chandler, Miranda Cumpston, Tianjing Li, Matthew Page, and Vivian Welch. It is freely available online at training.cochrane.org/handbook, runs to twenty-five chapters across four major parts, and represents roughly three decades of accumulated methodological consensus.
Version 6.5 and What Changed From Earlier Editions
The Handbook traces back to 1994, when the first version was distributed inside the early Cochrane Collaboration as internal guidance. Through the late 1990s and 2000s, Julian Higgins and Sally Green expanded it into a comprehensive methodological reference that became Version 5 and its successive sub-versions, which dominated systematic-review methodology training for over a decade.
The transition to Version 6.0 in 2019 was the most significant rewrite the Handbook has ever undergone. It coincided with three methodological shifts that the field had absorbed over the prior decade: the new risk-of-bias 2 tool for randomized trials, the maturation of the GRADE framework for rating certainty of evidence, and the imminent arrival of PRISMA 2020 reporting guidance. Version 6.0 was the first edition to integrate all three.
Version 6.5 in 2024 is an incremental but substantive update on Version 6.0. The headline changes are clearer guidance on handling synthesis without meta-analysis, an expanded treatment of equity considerations in review design, updated chapters on network meta-analysis and individual participant data, and refreshed examples throughout. Earlier subversions 6.1, 6.2, 6.3, and 6.4 had each added smaller updates between 2020 and 2023.
Editors, Authorship, and Governance
The Handbook is collectively edited by a group of senior Cochrane methodologists. The current edition lists seven lead editors: Julian Higgins (chief editor since the late 1990s), James Thomas, Jacqueline Chandler, Miranda Cumpston, Tianjing Li, Matthew Page, and Vivian Welch. Each chapter has its own lead authors drawn from the Cochrane Methods Groups, which are the standing working groups responsible for methodological development in specific areas such as statistics, bias, equity, qualitative evidence, and information retrieval.
This authorship structure matters when reading the Handbook. Some chapters are tightly aligned with formal Cochrane policy; others present methods that Cochrane recommends but does not yet require of all reviews; still others describe areas where the field is evolving and the Handbook chapter functions more like a state-of-the-art synthesis than a prescription. A reviewer who treats every sentence as policy will sometimes feel overconstrained. A reviewer who reads carefully will notice the distinctions between must, should, and may.
The Handbook is updated through a continuous-revision model rather than a fixed schedule. Between major versions, individual chapters can be revised when methodological evidence warrants. The version number and the publication date are visible on every chapter page, and reviewers writing a protocol should cite the specific version they are following so future readers know which guidance was in force.
Part I: Planning, Searching, Selecting, Extracting
The first six chapters of the Handbook cover the planning and preparatory phases of a systematic review. Chapter 1 introduces the rationale and process of a review. Chapter 2 defines the review question and the eligibility criteria using a structured framework such as PICO or one of its extensions. Chapter 3 covers searches for studies. Chapter 4 describes searching for and selecting studies. Chapter 5 covers data collection. Chapter 6 covers describing included studies.
The planning chapters establish what the Cochrane methodology insists on at the front end: a registered protocol before screening begins, a structured question with explicit population, intervention, comparator, outcome, and study design criteria, a comprehensive search across multiple databases with no language restrictions in the eligibility criteria when feasible, dual independent screening, and dual independent data extraction with adjudication of disagreements. These standards are tighter than what most non-Cochrane systematic reviews achieve in practice, and they are the operational core of the Cochrane versus non-Cochrane systematic reviews distinction.
Reviewers planning a non-Cochrane review can use Part I as a checklist. Even if you do not register with Cochrane, you can register with PROSPERO, use a Cochrane-style PICO, run a search planned with an information specialist, and conduct dual screening and extraction. These steps align your review with PRISMA 2020 reporting guidelines and signal to editors and peer reviewers that you have followed methodological best practice.
Part II: Statistical Methods and Synthesis
Chapters 7 through 15 cover the statistical and synthesis methods that make Cochrane reviews quantitative when feasible. Chapter 10 covers analyzing data and undertaking meta-analyses, including fixed-effect and random-effects models, weighting schemes, and the interpretation of heterogeneity. Chapter 11 covers undertaking network meta-analyses. Chapter 12 covers synthesis of qualitative evidence and synthesis when meta-analysis is not possible. Chapter 13 covers individual participant data reviews. Chapter 14 covers summary of findings tables and GRADE certainty ratings. Chapter 15 covers interpreting results and drawing conclusions.
The statistical chapters codify the default methodological choices that distinguish Cochrane reviews. Random-effects models are the default for most meta-analyses, although the Handbook discusses when fixed-effect models are appropriate. Heterogeneity is summarized using both I-squared as a percentage of variability and tau-squared as a between-study variance, and the limits of relying on I-squared alone are explicitly noted. Subgroup analyses are restricted to a small number pre-specified in the protocol. Sensitivity analyses are recommended around every methodological judgment.
Where the Handbook is most prescriptive in Part II is the GRADE framework for rating certainty of evidence. Every Cochrane intervention review is expected to include a summary of findings table containing the GRADE certainty rating for each main outcome, the relative effect, the absolute effect estimate, and a comment summarizing the reasons for downgrading or upgrading. This format has become the de facto standard for systematic reviews well beyond Cochrane, including non-Cochrane reviews aiming for high-impact publication.
Part III: Special Topics and Extensions
Part III collects chapters on special topics that intersect with mainstream systematic review methodology but require specialized methods. Chapter 19 covers adverse effects, addressing the methodological challenges of harms reviews where outcomes are often rare, poorly reported, and inconsistent in definition. Chapter 16 covers equity and specific populations, codifying methods for reviews concerned with whether interventions work equally well across socioeconomic, demographic, and geographic groups. Chapter 21 covers qualitative evidence synthesis, drawing on the methodological literature developed by the Cochrane Qualitative and Implementation Methods Group.
Other Part III chapters cover economic evidence, prognostic models, patient-reported outcomes, and rapid reviews. Many of these chapters are recent additions that did not exist in Version 5. They reflect the expansion of Cochrane's methodological scope from a narrow focus on randomized intervention trials in the 1990s to a broader portfolio of evidence syntheses that the field now expects.
For a reviewer outside the Cochrane orbit, Part III is often the most directly useful section. A non-Cochrane reviewer planning a systematic review of healthcare harms or a qualitative synthesis or a review with explicit equity aims will find chapter-length guidance that does not exist anywhere else with comparable rigor and accessibility.
